191 – 200 of 227
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer
(
- Contribution to journal › Article
-
Mark
Low-dose hormone therapy and carbohydrate metabolism.
(
- Contribution to journal › Article
-
Mark
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
(
- Contribution to journal › Article
-
Mark
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines
(
- Contribution to journal › Article
-
Mark
Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer - Clinical associations and reasons for discrepancies
(
- Contribution to journal › Article
-
Mark
Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
(
- Contribution to journal › Article
- 2002
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis
(
- Contribution to journal › Article
-
Mark
High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
(
- Contribution to journal › Article
-
Mark
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
(
- Contribution to journal › Article